Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitating protein synthesis, degradation, and endogenous antigen processing.

Michael F Princiotta1, Diana Finzi, Shu-Bing Qian

  • 1Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.

Immunity
|March 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-dose and very low-dose glucocorticoids: which low is low risk? - Authors' reply.

The Lancet. Rheumatology·2026
Same author

Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.

Annals of the rheumatic diseases·2026
Same author

Secukinumab for Giant Cell Arteritis.

NEJM evidence·2026
Same author

Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica.

The New England journal of medicine·2026
Same author

Comment on: Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumatica: reply.

Rheumatology (Oxford, England)·2026
Same author

Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis.

RMD open·2026
Same journal

Targeting cholesterol esterification sensitizes liver cancer to CD8<sup>+</sup> T cell attack by impairing metabolic and redox resilience.

Immunity·2026
Same journal

Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral pattern sensing.

Immunity·2026
Same journal

Extracellular ATP-P2RY2 signaling drives intratumoral prostaglandin E2 accumulation and adaptive resistance to immunotherapy in solid tumors.

Immunity·2026
Same journal

B cell-derived type I interferon sustains T cell functionality upon strong TCR stimulation during chronic infection.

Immunity·2026
Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026
Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026
See all related articles

This study quantifies protein synthesis and degradation rates in L929 cells, revealing the efficiency of generating MHC class I-peptide complexes from viral products. These findings are crucial for understanding T cell activation in immune cells like dendritic cells and macrophages.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Cells maintain protein homeostasis through synthesis and degradation.
  • MHC class I molecules present peptides to T cells, crucial for immune surveillance.
  • Understanding peptide generation efficiency is key to T cell activation.

Purpose of the Study:

  • To quantify the economics of protein synthesis and degradation in L929 cells.
  • To determine the efficiency of producing MHC class I-associated peptides from viral translation products.
  • To compare peptide production efficiency in immune cells involved in T cell activation.

Main Methods:

  • Utilized L929 cell line for quantitative analysis.
  • Measured rates of protein synthesis by ribosomes.

Related Experiment Videos

  • Quantitated protein degradation by proteasomes.

    • Main Results:

    • L929 cells maintain 2.6 x 10^9 proteins, with 6 x 10^6 ribosomes producing 4 x 10^6 proteins/min.
    • 8 x 10^5 proteasomes degrade 2.5 substrates/min.
    • One MHC class I-peptide complex is formed per 500-3000 viral translation products.
    • Similar complex formation efficiency observed in dendritic cells and macrophages.
    • Proteasomes exhibit differential efficiency in generating antigenic peptides from newly synthesized proteins (DRiPs) versus other pools.

    Conclusions:

    • Provides quantitative insights into cellular protein turnover and antigen presentation.
    • Highlights the role of proteasome efficiency in MHC class I peptide loading.
    • Findings are relevant to T cell activation mechanisms in vivo, particularly in antigen-presenting cells.